Novo Nordisk Long Term Debt 2010-2025 | NVO
Novo Nordisk long term debt from 2010 to 2025. Long term debt can be defined as the sum of all long term debt fields.
- Novo Nordisk long term debt for the quarter ending March 31, 2025 was $13.589B, a 456.75% increase year-over-year.
- Novo Nordisk long term debt for 2024 was $13.003B, a 336.24% increase from 2023.
- Novo Nordisk long term debt for 2023 was $2.981B, a 13.44% decline from 2022.
- Novo Nordisk long term debt for 2022 was $3.443B, a 66.99% increase from 2021.
Fatal error: Uncaught TypeError: number_format(): Argument #1 ($num) must be of type float, string given in /var/www/html/macrotrends/public_html/assets/php/new_chart_page_NEW.php:2765 Stack trace: #0 /var/www/html/macrotrends/public_html/assets/php/new_chart_page_NEW.php(2765): number_format() #1 /var/www/html/macrotrends/public_html/assets/php/url_router.php(168): include('...') #2 {main} thrown in /var/www/html/macrotrends/public_html/assets/php/new_chart_page_NEW.php on line 2765
Novo Nordisk Annual Long Term Debt (Millions of US $) |
|
---|---|
2024 | $13,003 |
2023 | $2,981 |
2022 | $3,443 |
2021 | $2,062 |
2020 | $444 |
2019 | $451 |
2018 |